DNDI-6148

CAT: 0804-HY-139854-01Size: 1 mgDry Ice: NoHazardous: No
CAT#:0804-HY-139854-01Size:1 mg
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
DNDI-6148 is a novel preclinical candidate for the research of visceral leishmaniasis.
CAS Number
[2243909-59-1]
UNSPSC
12352005
Target
Parasite
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/dndi-6148.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=C(C)N(C2=NC=CC=C2)N=N1)NC3=CC=C4C(B(O)OC4)=C3
Molecular Formula
C16H14BN5O3
Molecular Weight
335.13
References & Citations
[1]Mowbray CE, et al. DNDI-6148: A Novel Benzoxaborole Preclinical Candidate for the Treatment of Visceral Leishmaniasis. J Med Chem. 2021 Nov 11;64 (21) :16159-16176.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Leishmania

Popular Products